CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION

被引：4
|
作者：
Jiwa, Nasheena
Lorick, Kiran
Mutneja, Rahul
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.719
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：772A / 772A
页数：1
相关论文
共 50 条
  • [31] The IL-1?, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
    Schultheiss, Christoph
    Willscher, Edith
    Paschold, Lisa
    Gottschick, Cornelia
    Klee, Bianca
    Henkes, Svenja-Sibylla
    Bosurgi, Lidia
    Dutzmann, Jochen
    Sedding, Daniel
    Frese, Thomas
    Girndt, Matthias
    Hoell, Jessica I.
    Gekle, Michael
    Mikolajczyk, Rafael
    Binder, Mascha
    CELL REPORTS MEDICINE, 2022, 3 (06)
  • [32] A Case of Cytomegalovirus Colitis in an Immunocompetent COVID-19 Patient
    Bakir, Mohamad
    Rebh, Fatima
    Mahdi, Elham
    AlFiaar, Abdullah
    Mansoor, Gaafar S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [33] IL-6 blockade for COVID-19: a global scientific call to arms
    Murthy, Srinivas
    Lee, Todd C.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (05): : 438 - 440
  • [34] Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6
    Flisiak, Robert
    Jaroszewicz, Jerzy
    Rogalska, Magdalena
    Lapinski, Tadeusz
    Berkan-Kawinska, Aleksandra
    Bolewska, Beata
    Tudrujek-Zdunek, Magdalena
    Kozielewicz, Dorota
    Rorat, Marta
    Leszczynski, Piotr
    Klos, Krzysztof
    Kowalska, Justyna
    Pabjan, Pawel
    Piekarska, Anna
    Mozer-Lisewska, Iwona
    Tomasiewicz, Krzysztof
    Pawlowska, Malgorzata
    Simon, Krzysztof
    Polanska, Joanna
    Zarebska-Michaluk, Dorota
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (08)
  • [35] Clinical significance of IL-6 in severe and critical COVID-19 patients
    Kawamata, Takaya
    Tanino, Yoshinori
    Wang, Xintao
    Nikaido, Takefumi
    Sato, Yuki
    Togawa, Ryuichi
    Watanabe, Natsumi
    Saito, Koshi
    Kazama, Kentaro
    Harigane, Rina
    Yamada, Ryuki
    Tomita, Hikaru
    Rikimaru, Mami
    Morimoto, Julia
    Minemura, Hiroyuki
    Saito, Junpei
    Kanazawa, Kenya
    Shibata, Yoko
    RESPIROLOGY, 2023, 28 : 136 - 136
  • [36] Evolution of IL-6 as possible marker of viral control in Covid-19
    De Diego Ramos, C.
    Lopez, L.
    Torralba, L.
    Lasierra, A.
    Lahoz, R.
    Abadia, C.
    Ruiz De Gopegui, P.
    Cebollada, A.
    Godino, J.
    Jimeno, B.
    Bello, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [37] IL-6 Receptor Inhibitors in COVID-19: Efficacy on the Test Bench
    Wagner, Annkatrin
    TRANSFUSIONSMEDIZIN, 2021, 11 (03) : 151 - 151
  • [38] Relationship between IL-6 and COVID-19: to be considered during treatment
    Vatansever, Hafize Seda
    Becer, Eda
    FUTURE VIROLOGY, 2020, 15 (12) : 817 - 822
  • [39] IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
    Atal, Shubham
    Fatima, Zeenat
    PHARMACEUTICAL MEDICINE, 2020, 34 (04) : 223 - 231
  • [40] IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
    Shubham Atal
    Zeenat Fatima
    Pharmaceutical Medicine, 2020, 34 : 223 - 231
12345